No CrossRef data available.
Published online by Cambridge University Press: 08 February 2018
In the past few years papers have appeared in the U.S.A. and in Europe which discuss the role played by 5 hydroxy-tryptamine (serotonin) in cerebral metabolism, both in health and disease. The aim of this paper is to report a trial of a benzyl analogue of serotonin, a serotonin antagonist, and to shed some light upon its possible side-effects.
eLetters
No eLetters have been published for this article.